Toll-like receptor co-receptors as master regulators of the immune response

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 143-152

  Di Gioia, Marco ^a   Zanoni, Ivan ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Accessory molecules; CD14; CD36; DAMP; MAMP; Toll like receptor

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD14 ANTIGEN; CD36 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CRYSTAL STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; INTERNALIZATION; LIGAND BINDING; METABOLIC DISORDER; NONHUMAN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; IMMUNITY; IMMUNOLOGY;

ANIMALS; HUMANS; IMMUNITY; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84912000553     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.05.008     Document Type: Article

References (140)

1. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520.
2. Aitman T.J., Glazier A.M., Wallace C.A., Cooper L.D., Norsworthy P.J., Wahid F.N., Al-Majali K.M., Trembling P.M., Mann C.J., Shoulders C.C., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 1999, 21:76-83.
3. Aitman T.J., Cooper L.D., Norsworthy P.J., Wahid F.N., Gray J.K., Curtis B.R., McKeigue P.M., Kwiatkowski D., Greenwood B.M., Snow R.W., et al. Malaria susceptibility and CD36 mutation. Nature 2000, 405:1015-1016.
4. Alkhatatbeh M.J., Enjeti A.K., Acharya S., Thorne R.F., Lincz L.F. The origin of circulating CD36 in type 2 diabetes. Nutr. Diabetes 2013, 3:e59.
5. Andrade W.A., Souza M., do C., Ramos-Martinez E., Nagpal K., Dutra M.S., Melo M.B., Bartholomeu D.C., Ghosh S., Golenbock D.T., Gazzinelli R.T. Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to toxoplasma gondii in Mice. Cell Host Microbe 2013, 13:42-53.
6. Bae Y.S., Lee J.H., Choi S.H., Kim S., Almazan F., Witztum J.L., Melo M.B., Miller Y.I. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 2009, 104:210-218.
7. Baumann C.L., Aspalter I.M., Sharif O., Pichlmair A., Blüml S., Grebien F., Bruckner M., Pasierbek P., Aumayr K., Planyavsky M., et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J. Exp. Med. 2010, 207:2689-2701.
8. Bazil V., Horejsí V., Baudys M., Kristofová H., Strominger J.L., Kostka W., Hilgert I. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 1986, 16:1583-1589.
9. Beutler B. Innate immunity: an overview. Mol. Immunol. 2004, 40:845-859.
10. Borzecka K., Płóciennikowska A., Björkelund H., Sobota A., Kwiatkowska K. CD14 Mediates Binding of High Doses of LPS but is dispensable for TNF- (Production. Mediators Inflamm. 2013, 2013:824919.
11. Broz P., Ruby T., Belhocine K., Bouley D.M., Kayagaki N., Dixit V.M., Monack D.M. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012, 490:288-291.
12. Brundert M., Heeren J., Merkel M., Carambia A., Herkel J., Groitl P., Dobner T., Ramakrishnan R., Moore K.J., Rinninger F. Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells. J. Lipid Res. 2011, 52:745-758.
13. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 1999, 19:5237-5246.
14. Cerboni S., Gentili M., Manel N. Diversity of pathogen sensors in dendritic cells. Adv. Immunol. 2013, 120:211-237.
15. Chamilos G., Gregorio J., Meller S., Lande R., Kontoyiannis D.P., Modlin R.L., Gilliet M. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 2012, 120:3699-3707.
16. Choi S.-H., Harkewicz R., Lee J.H., Boullier A., Almazan F., Li A.C., Witztum J.L., Bae Y.S., Miller Y.I. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ. Res. 2009, 104:1355-1363.
17. Choi S.-H., Wiesner P., Almazan F., Kim J., Miller Y.I. Spleen tyrosine kinase regulates AP-1 dependent transcriptional response to minimally oxidized LDL. PLoS ONE 2012, 7.
18. Choi S.-H., Yin H., Ravandi A., Armando A., Dumlao D., Kim J., Almazan F., Taylor A.M., McNamara C.A., Tsimikas S., et al. Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages. PloS One 2013, 8:e83145.
19. Dziarski R., Tapping R.I., Tobias P.S. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 1998, 273:8680-8690.
20. Eckert J.K., Kim Y.J., Kim J.I., Gürtler K., Oh D.-Y., Sur S., Lundvall L., Hamann L., van der Ploeg A., Pickkers P., et al. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity 2013, 39:647-660.
21. El Khoury J.B., Moore K.J., Means T.K., Leung J., Terada K., Toft M., Freeman M.W., Luster A.D. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 2003, 197:1657-1666.
22. El-Yassimi A., Hichami A., Besnard P., Khan N.A. Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells. J. Biol. Chem. 2008, 283:12949-12959.
23. Erdman L.K., Cosio G., Helmers A.J., Gowda D.C., Grinstein S., Kain K.C. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J. Immunol. 2009, 1950(183):6452-6459.
24. Fassbender K., Walter S., Kühl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2004, 18:203-205.
25. Febbraio M., Silverstein R.L. CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 2007, 39:2012-2030.
26. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F.A., Silverstein R.L. A null mutation in Murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 1999, 274:19055-19062.
27. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105:1049-1056.
28. Fernández-Real J.M., Pérez del Pulgar S., Luche E., Moreno-Navarrete J.M., Waget A., Serino M., Sorianello E., Sánchez-Pla A., Pontaque F.C., Vendrell J., et al. CD14 modulates inflammation-driven insulin resistance. Diabetes 2011, 60:2179-2186.
29. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 2003, 198:1043-1055.
30. Franchi L., Muñoz-Planillo R., Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 2012, 13:325-332.
31. Gaillard D., Laugerette F., Darcel N., El-Yassimi A., Passilly-Degrace P., Hichami A., Khan N.A., Montmayeur J.-P., Besnard P. The gustatory pathway is involved in CD36-mediated orosensory perception of long-chain fatty acids in the mouse. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2008, 22:1458-1468.
32. Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F.J., Zal T., Gilliet M. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009, 206:1983-1994.
33. Gioannini T.L., Teghanemt A., Zhang D., Coussens N.P., Dockstader W., Ramaswamy S., Weiss J.P. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 2004, 101:4186-4191.
34. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., Rescigno M., Moro G., Ricciardi-Castagnoli P. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2001, 2:882-888.
35. Granucci F., Zanoni I., Pavelka N., van Dommelen S.L.H., Andoniou C.E., Belardelli F., Degli Esposti M.A., Ricciardi-Castagnoli P. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 2004, 200:287-295.
36. Gregorio J., Meller S., Conrad C., Nardo A.D., Homey B., Lauerma A., Arai N., Gallo R.L., DiGiovanni J., Gilliet M. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 2010, 207:2921-2930.
37. Gruarin P., Thorne R.F., Dorahy D.J., Burns G.F., Sitia R., Alessio M. CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport. Biochem. Biophys. Res. Commun. 2000, 275:446-454.
38. Hagar J.A., Powell D.A., Aachoui Y., Ernst R.K., Miao E.A. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013, 341:1250-1253.
39. Han D., Walsh M.C., Cejas P.J., Dang N.N., Kim Y.F., Kim J., Charrier-Hisamuddin L., Chau L., Zhang Q., Bittinger K., et al. Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity 2013, 38:1211-1222.
40. Harkewicz R., Hartvigsen K., Almazan F., Dennis E.A., Witztum J.L., Miller Y.I. Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein. J. Biol. Chem. 2008, 283:10241-10251.
41. Hawkes M., Li X., Crockett M., Diassiti A., Finney C., Min-Oo G., Liles W.C., Liu J., Kain K.C. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect. Dis. 2010, 10:299.
42. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., Goyert S.M. The monocyte differentiation antigen CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 1988, 141:547-552.
43. Haziot A., Ferrero E., Köntgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414.
44. Heit B., Kim H., Cosío G., Castaño D., Collins R., Lowell C.A., Kain K.C., Trimble W.S., Grinstein S. Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization. Dev. Cell 2013, 24:372-383.
45. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zähringer U., et al. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
46. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
47. Ivanov S., Dragoi A.-M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
48. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54(Pt 1):1-13.
49. Jersmann H.P. Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol. Cell Biol. 2005, 83:462-467.
50. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005, 6:565-570.
51. Jimenez-Dalmaroni M.J., Xiao N., Corper A.L., Verdino P., Ainge G.D., Larsen D.S., Painter G.F., Rudd P.M., Dwek R.A., Hoebe K., et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PloS One 2009, 4:e7411.
52. Joffre O., Nolte M.A., Spörri R., Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009, 227:234-247.
53. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell 2006, 125:943-955.
54. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 2008, 9:361-368.
55. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
56. Kayagaki N., Wong M.T., Stowe I.B., Ramani S.R., Gonzalez L.C., Akashi-Takamura S., Miyake K., Zhang J., Lee W.P., Muszyński A., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013, 341:1246-1249.
57. Kennedy D.J., Kuchibhotla S., Westfall K.M., Silverstein R.L., Morton R.E., Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc. Res. 2011, 89:604-613.
58. Khalifeh-Soltani A., McKleroy W., Sakuma S., Cheung Y.Y., Tharp K., Qiu Y., Turner S.M., Chawla A., Stahl A., Atabai K. Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids. Nat. Med. 2014, 20:175-183.
59. Kim J.-I., Lee C.J., Jin M.S., Lee C.-H., Paik S.-G., Lee H., Lee J.-O. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 2005, 280:11347-11351.
60. Kim S., Takahashi H., Lin W.-W., Descargues P., Grivennikov S., Kim Y., Luo J.-L., Karin M. Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
61. Kim S., Kim S.Y., Pribis J.P., Lotze M., Mollen K.P., Shapiro R., Loughran P., Scott M.J., Billiar T.R. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol. Med. Camb. Mass 2013, 19:88-98.
62. Koblansky A.A., Jankovic D., Oh H., Hieny S., Sungnak W., Mathur R., Hayden M.S., Akira S., Sher A., Ghosh S. Recognition of Profilin by toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013, 38:119-130.
63. Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.-J., Arnold B., Nawroth P., Andersson U., Harris R.A., Harris H.E. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 2005, 61:1-9.
64. Kulhankova K., Rouse T., Nasr M.E., Field E.H. Dendritic cells control CD4+CD25+Treg cell suppressor function in vitro through juxtacrine delivery of IL-2. PLoS ONE 2012, 7:e43609.
65. Kumar S., Gowda N.M., Wu X., Gowda R.N., Gowda D.C. CD36 modulates proinflammatory cytokine responses to Plasmodium falciparum glycosylphosphatidylinositols and merozoites by dendritic cells. Parasite Immunol. 2012, 34:372-382.
66. Lai Y., Adhikarakunnathu S., Bhardwaj K., Ranjith-Kumar C.T., Wen Y., Jordan J.L., Wu L.H., Dragnea B., Mateo L.S., Kao C.C. LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS ONE 2011, 6:e26632.
67. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.-H., Homey B., Cao W., Wang Y.-H., Su B., Nestle F.O., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
68. Laugerette F., Passilly-Degrace P., Patris B., Niot I., Febbraio M., Montmayeur J.-P., Besnard P. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J. Clin. Invest. 2005, 115:3177-3184.
69. Lee C.C., Avalos A.M., Ploegh H.L. Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol. 2012, 12:168-179.
70. Lee H.-K., Dunzendorfer S., Soldau K., Tobias P.S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 2006, 24:153-163.
71. Li X.-D., Chen Z.J. Sequence specific detection of bacterial 23S ribosomal RNA by TLR13. eLife 2012, 1:e00102.
72. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.-H., Cao X., Dawson M.I., Reed J.C., Zhang X. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004, 116:527-540.
73. Ling G.S., Bennett J., Woollard K.J., Szajna M., Fossati-Jimack L., Taylor P.R., Scott D., Franzoso G., Cook H.T., Botto M. Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages. Nat. Commun. 2014, 5:3039.
74. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
75. Liu S., Liu Y., Hao W., Wolf L., Kiliaan A.J., Penke B., Rübe C.E., Walter J., Heneka M.T., Hartmann T., et al. TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation. J. Immunol. 2012, 1950(188):1098-1107.
76. Liu Y., Walter S., Stagi M., Cherny D., Letiembre M., Schulz-Schaeffer W., Heine H., Penke B., Neumann H., Fassbender K. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain J. Neurol. 2005, 128:1778-1789.
77. Lopez-Dee Z., Pidcock K., Gutierrez L.S. Thrombospondin-1: multiple paths to inflammation. Mediators Inflamm. 2011, 2011.
78. Manukyan M., Triantafilou K., Triantafilou M., Mackie A., Nilsen N., Espevik T., Wiesmüller K.-H., Ulmer A.J., Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14 TLR2 and TLR1. Eur. J. Immunol. 2005, 35:911-921.
79. Mathison J.C., Tobias P.S., Wolfson E., Ulevitch R.J. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J. Immunol. 1992, 1950(149):200-206.
80. Mathur R., Oh H., Zhang D., Park S.-G., Seo J., Koblansky A., Hayden M.S., Ghosh S. A mouse model of Salmonella typhi infection. Cell 2012, 151:590-602.
81. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
82. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
83. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 2003, 278:1561-1568.
84. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., Witztum J.L. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1213-1219.
85. Nakata T., Yasuda M., Fujita M., Kataoka H., Kiura K., Sano H., Shibata K. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 2006, 8:1899-1909.
86. O'Neill L.A.J. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 2008, 29:12-20.
87. O'Neill L.A.J., Golenbock D., Bowie A.G. The history of Toll-like receptors-redefining innate immunity. Nat. Rev. Immunol. 2013, 13:453-460.
88. Oldenburg M., Krüger A., Ferstl R., Kaufmann A., Nees G., Sigmund A., Bathke B., Lauterbach H., Suter M., Dreher S., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012, 337:1111-1115.
89. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y.M. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002, 347:1151-1160.
90. Park B.S., Song D.H., Kim H.M., Choi B.-S., Lee H., Lee J.-O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458:1191-1195.
91. Park J.S., Arcaroli J., Yum H.-K., Yang H., Wang H., Yang K.-Y., Choe K.-H., Strassheim D., Pitts T.M., Tracey K.J., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-C879.
92. Park J.S., Svetkauskaite D., He Q., Kim J.-Y., Strassheim D., Ishizaka A., Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
93. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.-Y., Strassheim D., Sohn J.-W., Yamada S., Maruyama I., Banerjee A., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:C917-C924.
94. Patel S.N., Lu Z., Ayi K., Serghides L., Gowda D.C., Kain K.C. Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J. Immunol. 2007, 178:3954-3961.
95. Perera P.Y., Vogel S.N., Detore G.R., Haziot A., Goyert S.M. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol. 1997, 1950(158):4422-4429.
96. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
97. Raetz M., Kibardin A., Sturge C.R., Pifer R., Li H., Burstein E., Ozato K., Larin S., Yarovinsky F. Cooperation of TLR12 and TLR11 in the IRF8-dependent IL-12 response to Toxoplasma gondii profilin. J. Immunol.V 1950 2013, (191):4818-4827.
98. Rapsinski G.J., Newman T.N., Oppong G.O., van Putten J.P.M., Tükel Ç CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J. Biol. Chem. 2013, 288:14178-14188.
99. Rathinam V.A.K., Vanaja S.K., Waggoner L., Sokolovska A., Becker C., Stuart L.M., Leong J.M., Fitzgerald K.A. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012, 150:606-619.
100. Reed-Geaghan E.G., Reed Q.W., Cramer P.E., Landreth G.E. Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:15369-15373.
101. Regan T., Nally K., Carmody R., Houston A., Shanahan F., Macsharry J., Brint E. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J. Immunol. 2013, 1950(191):6084-6092.
102. Roy S., Karmakar M., Pearlman E. CD14 mediates toll-like receptor 4 (TLR4) endocytosis and spleen tyrosine kinase (Syk) and interferon regulatory transcription factor 3 (IRF3) activation in epithelial cells and impairs neutrophil infiltration and Pseudomonas aeruginosa killing in vivo. J. Biol. Chem. 2014, 289:1174-1182.
103. Sandgren S., Wittrup A., Cheng F., Jönsson M., Eklund E., Busch S., Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 2004, 279:17951-17956.
104. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
105. Schröder N.W.J., Morath S., Alexander C., Hamann L., Hartung T., Zähringer U., Göbel U.B., Weber J.R., Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 2003, 278:15587-15594.
106. Schumann R.R., Kirschning C.J., Unbehaun A., Aberle H.P., Knope H.P., Lamping N., Ulevitch R.J., Herrmann F. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 1996, 16:3490-3503.
107. + regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity 2011, 44:406-414.
108. Sheedy F.J., Grebe A., Rayner K.J., Kalantari P., Ramkhelawon B., Carpenter S.B., Becker C.E., Ediriweera H.N., Mullick A.E., Golenbock D.T., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 2013, 14:812-820.
109. Simmons D.L., Tan S., Tenen D.G., Nicholson-Weller A., Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989, 73:284-289.
110. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
111. Stros M., Ozaki T., Bacikova A., Kageyama H., Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J. Biol. Chem. 2002, 277:7157-7164.
112. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., Ezekowitz R.A.B., Moore K.J. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 2005, 170:477-485.
113. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., Tanji N., Lu Y., Lalla E., Fu C., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
114. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
115. Tang D., Shi Y., Kang R., Li T., Xiao W., Wang H., Xiao X. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukoc. Biol. 2007, 81:741-747.
116. Thomas L., Bielemeier A., Lambert P.A., Darveau R.P., Marshall L.J., Devitt A. The N-terminus of CD14 acts to bind apoptotic cells and confers rapid-tethering capabilities on non-myeloid cells. PLoS ONE 2013, 8:e70691.
117. Thorgersen E.B., Pischke S.E., Barratt-Due A., Fure H., Lindstad J.K., Pharo A., Hellerud B.C., Mollnes T.E. Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis. Infect. Immun. 2013, 81:3173-3181.
118. Tian J., Avalos A.M., Mao S.-Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007, 8:487-496.
119. Travis S.M., Anderson N.N., Forsyth W.R., Espiritu C., Conway B.D., Greenberg E.P., McCray P.B., Lehrer R.I., Welsh M.J., Tack B.F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 2000, 68:2748-2755.
120. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002, 115:2603-2611.
121. Triantafilou M., Gamper F.G.J., Haston R.M., Mouratis M.A., Morath S., Hartung T., Triantafilou K. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 2006, 281:31002-31011.
122. Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Kimoto M. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Int. Immunol. 2010, 22:271-280.
123. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17:1410-1422.
124. Weber C., Müller C., Podszuweit A., Montino C., Vollmer J., Forsbach A. Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 2012, 136:64-77.
125. West K.L., Castellini M.A., Duncan M.K., Bustin M. Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1. Mol. Cell. Biol. 2004, 24:3747-3756.
126. West M.A., Wallin R.P.A., Matthews S.P., Svensson H.G., Zaru R., Ljunggren H.-G., Prescott A.R., Watts C. Enhanced dendritic cell antigen capture via Toll-Like receptor-induced actin remodelling. Science 2004, 305:1153-1157.
127. Wiesner P., Choi S.H., Almazan F., Benner C., Huang W., Diehl C.J., Gonen A., Butler S., Witztum J.L., Glass C.K., Miller Y.I. Low doses of lipopolysaccharide and minimally oxidized low-density lipoproteincooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ. Res. 2010, 107(1):56-65. Epub 2010 May 20. 10.1161/CIRCRESAHA.110.218420.
128. Wiersinga W.J., de Vos A.F., Wieland C.W., Leendertse M., Roelofs J.J.T.H., van der Poll T. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice. J. Infect. Dis. 2008, 198:1388-1397.
129. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
130. Wuest S.C., Edwan J.H., Martin J.F., Han S., Perry J.S.A., Cartagena C.M., Matsuura E., Maric D., Waldmann T.A., Bielekova B. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 2011, 17:604-609.
131. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 2003, 4:1144-1150.
132. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009, 462:99-103.
133. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., Hieny S., Sutterwala F.S., Flavell R.A., Ghosh S., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
134. Zanoni I., Granucci F. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance. Autoimmunity 2011, 44:23-32.
135. Zanoni I., Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front. Cell. Infect. Microbiol. 2013, 3:32.
136. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A.E., Rocchetti M., Mingozzi F., Foti M., Chirico G., et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009, 460:264-268.
137. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
138. Zanoni I., Ostuni R., Barresi S., Di Gioia M., Broggi A., Costa B., Marzi R., Granucci F. CD14 and NFAT mediate lipopolysaccharide-induced skin edema formation in mice. J. Clin. Invest 2012, 122:1747-1757.
139. Zanoni I., Bodio C., Broggi A., Ostuni R., Caccia M., Collini M., Venkatesh A., Spreafico R., Capuano G., Granucci F. Similarities and differences of innate immune responses elicited by smooth and rough LPS. Immunol. Lett. 2012, 142:41-47.
140. Zanoni I., Spreafico R., Bodio C., Di Gioia M., Cigni C., Broggi A., Gorletta T., Caccia M., Chirico G., Sironi L., et al. IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions. Cell Rep. 2013, 4:1235-1249.